
Search
Filter Results
Displaying 101–110 of 689 for “retinitis clinical trial”
-
Jul 28, 2023
Belite Bio Doses First Patient in Phase 3 Clinical Trial for Advanced Dry AMD (GA) Therapy
The company’s emerging, oral treatment is designed to slow vision loss
-
Feb 11, 2021
Are You on the Clinical Trial Radar Screen?
Therapy developers use the My Retina Tracker Registry to recruit for human studies of emerging therapies
-
May 28, 2020
Genentech’s Port Delivery System for Wet AMD Meets Primary Endpoint in Phase 3 Clinical Trial
Tiny implant provides continual delivery of anti-VEGF treatment for six months
-
Mar 5, 2020
First Patient Receives Emerging CRISPR Therapy in Clinical Trial for LCA 10
First time emerging CRISPR therapy administered inside the human body
-
May 12, 2025
Part B of the trial will enroll nine adult patients as well as three pediatric patients.
-
May 13, 2022
Enhanced Implantable Miniature Telescope Moving into Clinical Trial for AMD Patients
The device is designed for people with late-stage AMD who have no treatment options
-
Jul 19, 2017
Twelve People Receive XLRS Gene Therapy in AGTC's Clinical Trial
AGTC’s gene therapy uses a human-engineered virus — and adeno-associated virus or AAV — to deliver normal copies of retinoschisin to the patient’s retina.
-
Apr 28, 2016
ARVO 2016: Choroideremia Gene Therapy in Clinical Trial Continues to Perform Well
Five of six patients in NightStaRx’s choroideremia gene-therapy trial continue to benefit from the treatment.
-
Mar 7, 2022
Neurogene to Launch Gene Therapy Clinical Trial for Children with Batten Disease
The treatment will be delivered to the vitreous of the eye and ventricles of the brain
-
Sep 30, 2021
The emerging treatment targets a specific mutation (c.2991+1655A>G in Intron 26) of the gene CEP290 which causes Leber congenital amaurosis 10 (LCA 10)